Royal Bank of Canada
SNTI icon

Royal Bank of Canada’s Senti Biosciences Holdings SNTI Stock Holding History

Royal Bank of Canada’s Portfolio SNTI Stock Details SNTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-50
Closed – – 7541
2023
Q3 		$0 Sell
50
-47
-48% -$323 ﹤0.01% 7539
2023
Q2 		$1K Buy
+97
New +$947 ﹤0.01% 7073
2021
Q4 		– Sell
-30
Closed -$3K – 7872
2021
Q3 		$3K Buy
+30
New +$2.96K ﹤0.01% 7273

Other funds holding SNTI

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
8GI
8VC GP I Austin, Texas $39.6M AUM 36.39% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Intel Corp Santa Clara, California $470M AUM 21.74% 1-Year Est. Return
TM
Triatomic Management Palo Alto, California $3.39M AUM 3.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Royal Bank of Canada's SNTI Position: Q4 2023 in Review

Royal Bank of Canada sold out of Senti Biosciences Holdings (SNTI) in Q4 2023, closing a stake of 50 shares.

Royal Bank of Canada first reported a position in SNTI in Q3 2021 and held it in 3 quarters. The position peaked at $3K in Q3 2021. 25 funds tracked by Wall St. Rank hold SNTI as of Q4 2023.

  • Royal Bank of Canada reported no remaining Senti Biosciences Holdings position as of Q4 2023 after selling out during the quarter.
  • Royal Bank of Canada sold 50 Senti Biosciences Holdings shares in Q4 2023.
  • Royal Bank of Canada first reported a position in Senti Biosciences Holdings in Q3 2021 and held it in 3 quarters.
  • Royal Bank of Canada's Senti Biosciences Holdings position peaked at $3K in Q3 2021.
  • 25 funds tracked by Wall St. Rank held Senti Biosciences Holdings as of Q4 2023.

Based on Royal Bank of Canada's 13F filing for Q4 2023, filed 14 Feb 2024.